Juan Lopez-Belmonte Encina, Chairman & Chief Executive Officer, Ten Percent Owner at Laboratorios Farmaceuticos Rovi, holds 32.62M shares in Laboratorios Farmaceuticos Rovi (Ticker: GB:0ILL). Most recently, Juan Lopez-Belmonte Encina Sold €560,690 shares of Laboratorios Farmaceuticos Rovi on Jun 29, 2022 for an estimated value of 32.80M.
What is the percentage of profitable transactions made by Juan Lopez-Belmonte Encina?
The percentage of profitable transactions made by Juan Lopez-Belmonte Encina is 75%.
What is the average return per transaction made by Juan Lopez-Belmonte Encina?
The average return per transaction made by Juan Lopez-Belmonte Encina is 32.50%.
What stocks does Juan Lopez-Belmonte Encina hold?
Juan Lopez-Belmonte Encina holds: GB:0ILL stocks.
What was Juan Lopez-Belmonte Encina’s latest transaction?
Juan Lopez-Belmonte Encina latest transaction was an Informative Sell of €32.80M.
What was Juan Lopez-Belmonte Encina's most profitable transaction?
Juan Lopez-Belmonte Encina’s most profitable transaction was an Informative Buy of GB:0ILL stock on November 13, 2014. The return on the trade was 71.80%.
What is Juan Lopez-Belmonte Encina's role in Laboratorios Farmaceuticos Rovi?
Juan Lopez-Belmonte Encina's role in Laboratorios Farmaceuticos Rovi is Chairman & Chief Executive Officer, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.